FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2132785093> ?p ?o ?g. }

• W2132785093 endingPage "2856" @default.
• W2132785093 startingPage "2846" @default.
• W2132785093 abstract "Rett Syndrome is a neurodevelopmental autism spectrum disorder caused by mutations in the gene coding for methyl CpG-binding protein (MeCP2). The disease is characterized by abnormal motor, respiratory, cognitive impairment, and autistic-like behaviors. No effective treatment of the disorder is available. Mecp2 knockout mice have a range of physiological and neurological abnormalities that resemble the human syndrome and can be used as a model to interrogate new therapies. Herein, we show that the combined administration of Levodopa and a Dopa-decarboxylase inhibitor in RTT mouse models is well tolerated, diminishes RTT-associated symptoms, and increases life span. The amelioration of RTT symptomatology is particularly significant in those features controlled by the dopaminergic pathway in the nigrostratium, such as mobility, tremor, and breathing. Most important, the improvement of the RTT phenotype upon use of the combined treatment is reflected at the cellular level by the development of neuronal dendritic growth. However, much work is required to extend the duration of the benefit of the described preclinical treatment." @default.
• W2132785093 created "2016-06-24" @default.
• W2132785093 creator A5003826728 @default.
• W2132785093 creator A5010137759 @default.
• W2132785093 creator A5010411679 @default.
• W2132785093 creator A5024927527 @default.
• W2132785093 creator A5033973697 @default.
• W2132785093 creator A5045230759 @default.
• W2132785093 creator A5053519511 @default.
• W2132785093 creator A5055473870 @default.
• W2132785093 creator A5058583468 @default.
• W2132785093 creator A5066434108 @default.
• W2132785093 creator A5077142284 @default.
• W2132785093 creator A5083264466 @default.
• W2132785093 creator A5083908023 @default.
• W2132785093 date "2014-06-11" @default.
• W2132785093 modified "2023-10-18" @default.
• W2132785093 title "Improvement of the Rett Syndrome Phenotype in a Mecp2 Mouse Model Upon Treatment with Levodopa and a Dopa-Decarboxylase Inhibitor" @default.
• W2132785093 cites W1559742681 @default.
• W2132785093 cites W1969998076 @default.
• W2132785093 cites W1974139119 @default.
• W2132785093 cites W1978127185 @default.
• W2132785093 cites W1979223448 @default.
• W2132785093 cites W1979822748 @default.
• W2132785093 cites W1981495424 @default.
• W2132785093 cites W1987360554 @default.
• W2132785093 cites W1999775510 @default.
• W2132785093 cites W2000313340 @default.
• W2132785093 cites W2001657520 @default.
• W2132785093 cites W2003493421 @default.
• W2132785093 cites W2005223902 @default.
• W2132785093 cites W2008964449 @default.
• W2132785093 cites W2014402840 @default.
• W2132785093 cites W2017233848 @default.
• W2132785093 cites W2017758442 @default.
• W2132785093 cites W2018107367 @default.
• W2132785093 cites W2021996855 @default.
• W2132785093 cites W2027173744 @default.
• W2132785093 cites W2028904201 @default.
• W2132785093 cites W2039294355 @default.
• W2132785093 cites W2041097941 @default.
• W2132785093 cites W2041174212 @default.
• W2132785093 cites W2047755869 @default.
• W2132785093 cites W2048273592 @default.
• W2132785093 cites W2068277204 @default.
• W2132785093 cites W2068522093 @default.
• W2132785093 cites W2079537073 @default.
• W2132785093 cites W2082787641 @default.
• W2132785093 cites W2083421199 @default.
• W2132785093 cites W2084589576 @default.
• W2132785093 cites W2091612053 @default.
• W2132785093 cites W2098163359 @default.
• W2132785093 cites W2099287930 @default.
• W2132785093 cites W2099862428 @default.
• W2132785093 cites W2103019088 @default.
• W2132785093 cites W2103964804 @default.
• W2132785093 cites W2107251840 @default.
• W2132785093 cites W2108470366 @default.
• W2132785093 cites W2113806391 @default.
• W2132785093 cites W2116309538 @default.
• W2132785093 cites W2127311839 @default.
• W2132785093 cites W2140481775 @default.
• W2132785093 cites W2152668149 @default.
• W2132785093 cites W2161944843 @default.
• W2132785093 cites W2168126378 @default.
• W2132785093 doi "https://doi.org/10.1038/npp.2014.136" @default.
• W2132785093 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4200495" @default.
• W2132785093 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24917201" @default.
• W2132785093 hasPublicationYear "2014" @default.
• W2132785093 type Work @default.
• W2132785093 sameAs 2132785093 @default.
• W2132785093 citedByCount "22" @default.
• W2132785093 countsByYear W21327850932015 @default.
• W2132785093 countsByYear W21327850932016 @default.
• W2132785093 countsByYear W21327850932017 @default.
• W2132785093 countsByYear W21327850932018 @default.
• W2132785093 countsByYear W21327850932019 @default.
• W2132785093 countsByYear W21327850932020 @default.
• W2132785093 countsByYear W21327850932021 @default.
• W2132785093 countsByYear W21327850932022 @default.
• W2132785093 countsByYear W21327850932023 @default.
• W2132785093 crossrefType "journal-article" @default.
• W2132785093 hasAuthorship W2132785093A5003826728 @default.
• W2132785093 hasAuthorship W2132785093A5010137759 @default.
• W2132785093 hasAuthorship W2132785093A5010411679 @default.
• W2132785093 hasAuthorship W2132785093A5024927527 @default.
• W2132785093 hasAuthorship W2132785093A5033973697 @default.
• W2132785093 hasAuthorship W2132785093A5045230759 @default.
• W2132785093 hasAuthorship W2132785093A5053519511 @default.
• W2132785093 hasAuthorship W2132785093A5055473870 @default.
• W2132785093 hasAuthorship W2132785093A5058583468 @default.
• W2132785093 hasAuthorship W2132785093A5066434108 @default.
• W2132785093 hasAuthorship W2132785093A5077142284 @default.
• W2132785093 hasAuthorship W2132785093A5083264466 @default.
• W2132785093 hasAuthorship W2132785093A5083908023 @default.
• W2132785093 hasBestOaLocation W21327850931 @default.
• W2132785093 hasConcept C104317684 @default.
• W2132785093 hasConcept C118552586 @default.

• next